New fall COVID-19 guidance includes new restrictions

The Food and Drug Administration has approved the next round of COVID boosters for the fall, further limiting who can receive the shot. — Image credit: Jeffrey Greenberg/Universal Images Group via Getty Images

This recording was made using enhanced software.

Summary

FDA booster guidance

The Food and Drug Administration has updated its COVID-19 booster guidance for the fall, now recommending that only adults 65 and older and children with at least one underlying condition should routinely receive the updated shot.

Official reactions

Kennedy called the new guidance "science, safety and common sense," and claimed the decision marks the end of what he called "Biden’s general mandate."

CDC panel composition

The article states that the CDC vaccine panel, which will next review the evidence and make recommendations regarding booster eligibility, now consists entirely of new members after Kennedy dismissed the previous 17 members in June.

Full story

The Food and Drug Administration has approved the next round of COVID boosters for the fall, further limiting who can receive the shot. The new guidance now states that only high-risk groups should routinely receive the updated vaccine.

Those approved are adults 65 and older, and children with at least one underlying condition.

Download the SAN app today to stay up-to-date with Unbiased. Straight Facts™.

Point phone camera here

Department of Health and Human Services Secretary Robert F. Kennedy Jr. celebrated the move on X, calling it “science, safety and common sense.” In the post, he declared the days of “Biden’s general mandate” over.

I promised 4 things:

1. to end covid vaccine mandates.

2. to keep vaccines available to people who want them, especially the vulnerable.

3. to demand placebo-controlled trials from companies.

4. to end the emergency.

In a series of FDA actions today we accomplished…
— Secretary Kennedy (@SecKennedy) August 27, 2025

Doctors can still prescribe the vaccine to others outside those groups, but they won’t be able to simply walk into a pharmacy and get it. It’s unclear whether insurance will cover the cost for anyone not recommended.

Kennedy also announced that the emergency use authorizations have been rescinded.

Response to the new guidelines

The president of the American Academy of Pediatrics described the tighter guidelines as “deeply troubling.”

“As we enter respiratory virus season, any barrier to COVID-19 vaccination creates a dangerous vulnerability for children and their families. Respiratory illnesses can be especially risky for infants and toddlers, whose airways and lungs are small and still developing,” Dr. Susan Kressly said.

CDC vaccine panel approval

The next step involves a CDC vaccine panel considering the evidence before making final recommendations on who should receive the shot.

The panel has all new members after Kennedy fired the previous 17 members in June. The new members, all of whom are doctors or Ph.D. holders, include several individuals with controversial views on COVID-19 vaccines

Craig Nigrelli

Craig Nigrelli is an anchor and reporter for Straight Arrow News.

Julia Marshall

Julia Marshall is a morning digital producer at Straight Arrow News. Thanks to her extensive newsroom experience, Julia has a keen eye for news and extensive experience in writing and editing content across all topics and platforms.

Tags: COVID-19, FDA, Robert F. Kennedy Jr., Vaccine mandate

[craig nigrelli]

AND STAYING WITH PUBLIC HEALTH… NEW COVID SHOT GUIDELINES ARE OUT THIS MORNING, AND THE WINDOW JUST GOT A LOT NARROWER.

THE FDA NOW SAYS ONLY HIGH-RISK GROUPS SHOULD ROUTINELY GET THE UPDATED SHOT: ADULTS 65 AND OVER, AND CHILDREN WITH AT LEAST ONE UNDERLYING CONDITION.

HEALTH AND HUMAN SERVICES SECRETARY ROBERT F. KENNEDY JR., CELEBRATED THE MOVE ON X — CALLING IT “SCIENCE, SAFETY AND COMMON SENSE” — AND DECLARING THE DAYS OF “BIDEN’S GENERAL MANDATE” OVER.

DOCTORS CAN STILL PRESCRIBE THE VACCINE TO OTHERS OUTSIDE THOSE GROUPS, BUT THEY WON’T BE ABLE TO SIMPLY WALK INTO A PHARMACY AND GET IT.

AND IT’S UNCLEAR WHETHER INSURANCE WILL COVER THE OCST FOR ANYONE NOT RECOMMENDED.

THE PRESIDENT OF THE AMERICAN ACADEMY OF PEDIATRICS CALLED THE TIGHTER GUIDELINES “DEEPLY TROUBLING. “

THE NEXT STEP: A CDC VACCINE PANEL WEIGHS IN, BEFORE ISSUING FINAL RECOMMENDATIONS ON WHO SHOULD GET THE SHOT.

Why this story matters

FDA recommendations on COVID-19 booster eligibility are shifting, impacting vaccine access and prompting debate among medical professionals about the potential health consequences for groups outside the new guidelines.

Vaccine eligibility

The decision limits routine access to COVID-19 boosters to adults over 65 and high-risk children, raising questions about protection for others and who can access vaccines through alternative means.

Medical guidance controversy

Medical organizations and doctors have expressed concern about the narrower recommendations. Dr. Susan Kressly, president of the American Academy of Pediatrics, described the guidelines as "deeply troubling" due to risks for young children.

Policy and leadership changes

The CDC vaccine panel now consists entirely of new members, some with controversial views on COVID-19 vaccines, illustrating how policy and personnel changes may shape future public health guidance.

Get the big picture

Synthesized coverage insights across 72 media outlets

Context corner

Universal COVID-19 vaccine recommendations were previously standard in the US, but changing immunity levels and declining vaccination rates have led to narrower federal guidance based on risk factors like age and underlying health conditions.

Do the math

AAP estimates a COVID-19 vaccine for a child could cost families about $200 if not covered by insurance. CDC data indicate there were 48 hospitalizations per 100,000 US children under five last season.

Global impact

The US is not alone in reducing broad COVID-19 vaccination recommendations; other countries have similarly scaled back universal booster campaigns in recent years as population immunity has increased.

International

4 hrs ago

3 min read

High-speed trains collide in Spain, killing at least 39 in rare double derailment
U.S.

5 hrs ago

12 min read

Europe weighs response to Trump; Spain train crash kills dozens
Politics

5 hrs ago

4 min read

Europe unites against Trump’s Greenland tariffs threat, emergency summit called
International

17 hrs ago

3 min read

Trump says Iran needs ‘new leadership’ amid ongoing protests

Sources

Media landscape

Click on bars to see headlines

72 total sources

Key points from the Left

U.S. regulators approved Pfizer's updated COVID-19 shot with new access limits for some adults and children who have high-risk health conditions, as stated by the Food and Drug Administration.
The FDA's new rules present barriers for millions who need to prove their health risks to receive the vaccine.
Pfizer’s vaccine will not be available for children under age 5 after the FDA revoked its emergency authorization for that age group.
Medical groups like the American Academy of Pediatrics have opposed the new limits, stating they may block access for families seeking to protect their children.

Report an issue with this summary

Key points from the Center

On Aug. 27, 2025, the FDA approved updated Pfizer COVID-19 boosters but limited vaccine access for many children and younger adults across the U.S.
This decision reflects a shift from previous policies that broadly recommended annual COVID shots for everyone over 6 months, driven by skepticism about risks and booster necessity.
The FDA rescinded emergency use authorizations for some vaccines, notably limiting Pfizer’s pediatric shot availability for children under 5 and narrowing eligibility to higher-risk groups.
Robert F. Kennedy Jr. announced that the changes meet commitments to end vaccine mandates and maintain vaccine access for those at high risk, highlighting that these actions respond to the public’s call for evidence-based policies, safety and practical judgment.
This new framework may complicate access for millions, including healthy children and younger adults, as insurance coverage and physician willingness remain uncertain amid rising COVID-19 cases.

Report an issue with this summary